semaglutide and kidney problems FLOWing with the — NephJC Ozempic Slows Kidney Disease, Now

This FDA-approved injectable targets the underlying causes of facial aging, stimulating collagen production to restore youthful volume and smoothness

The first biosimilar formulation of a GLP-1 receptor agonist, liraglutide, has recently been marketed, at a lower acquisition cost than the original formulation, whilst oral semaglutide remains the only currently available GLP-1 receptor agonist that is administered orally

Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of its $3.1 billion takeover of Carmot Therapeutics

PS: I would love to hear your thoughts on whether data from medical toxicology and poison centers could be beneficial in generating hypotheses for target identification in drug discovery

See why NVO stock is a Buy.